Charles Vista was agent; common shares sold with five-year warrants
By Devika Patel
Knoxville, Tenn., March 6 - DelMar Pharmaceuticals, Inc. completed a $954,951 private placement of units on Feb. 28, March 1 and March 6, according to an 8-K filed Wednesday with the Securities and Exchange Commission. Charles Vista, LLC was the agent.
The company sold 1,193,689 units of one common share and one warrant at $0.80 per unit.
Each warrant is exercisable at $0.80 for five years. The strike price reflects a 76.47% discount to $3.40, the closing share price on Feb. 27.
The drug developer is based in Red Bank, N.J.
| Issuer: | DelMar Pharmaceuticals, Inc.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | $954,951
|
| Shares: | 1,193,689
|
| Price: | $0.80
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $0.80
|
| Agent: | Charles Vista, LLC
|
| Settlement date: | Feb. 28, March 1 and March 6
|
| Stock symbol: | OTCBB: DMPI
|
| Stock price: | $3.40 at close Feb. 27
|
| Market capitalization: | $37.84 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
